Ebola survivor urges increased production of experimental drug

Kyndy Kobba, a physician's assistant who survived Ebola after receiving ZMapp in Liberia, urged the manufacturer of the experimental drug to step up production and distribute it in Africa.

A Liberian health worker who recovered from Ebola after receiving an experimental drug urged the manufacturer to speed up its production and send it to Africa, while crowds celebrated in the streets Saturday after authorities reopened a slum that had been barricaded for more than a week to try to contain the disease.

Physician's assistant Kyndy Kobbah was expected to be released from hospital Saturday after she survived Ebola, which has been fatal in more than half the cases sweeping West Africa. Kobbah contracted the disease while working at a government-run hospital north of the capital.

In an interview with The Associated Press before her release, she said when she informed her family that she had been cured, the home exploded with joy "and the house is on fire right now" with celebration.

"I am very fine and all right, glory be to God," she said. "I trusted God that I was going to be healed."

Kobbah urged the manufacturer of the experimental drug known as ZMapp to step up production. The company has said that all its supplies are exhausted and it will take months to make more.

"They need to make more Zmapp and send to us," she said.

Doctors have said there is no way to know whether ZMapp made a difference or if survivors like Kobbah recovered on their own, as about 45 percent of people infected in this outbreak have. The drug had never been tested in humans before it was given to two Americans who were infected with Ebola in Liberia. They survived Ebola and were released from an Atlanta hospital.

However, a study released online Friday by the journal Nature found that ZMapp healed all 18 monkeys infected with the deadly virus.

Meanwhile, tensions diminished Saturday in the West Point neighborhood of Liberia's capital after authorities lifted a blockade that had sparked unrest. Residents living in the area had feared running out of food and safe water on the peninsula.

Liberia's president had ordered the barricade on Aug. 19 after West Point residents stormed an Ebola health center several days earlier. Residents said they did not want sick people being brought into the community, although those staying at the center were only under observation during a 21-day incubation period.

Amid the melee, some protesters made off with blood-stained mattresses and other materials that could potentially spread the Ebola virus.

Lifting the quarantine Saturday morning doesn't mean there is no Ebola in the West Point slum, said Information Minister Lewis Brown. Authorities, though, are more confident now that they can work with residents to screen for the sick, he said.

"They're comfortable with the way the leadership and the community is working with the health team to make sure that the community remains safe," he said.

Liberia has been the hardest hit of the five countries with Ebola cases in West Africa, reporting at least 694 deaths among 1,378 cases. More than 3,000 cases have been reported across Liberia, Guinea, Sierra Leone and Nigeria, and on Friday Senegal announced its first case.

A student from Guinea who had been missing for several weeks showed up at a hospital in Dakar on Tuesday, seeking treatment but concealing that he had been in contact with other Ebola victims, Health Minister Awa Marie Coll Seck confirmed.

The next day, an epidemiological surveillance team in neighboring Guinea alerted Senegalese authorities that they had lost track of a person they were monitoring three weeks earlier, and that the person may have crossed into Senegal.

The student was tracked down in the Dakar hospital where he was confirmed with Ebola and immediately put into isolation where he is reported to be in satisfactory condition, Seck said. Authorities also sent out a team to disinfect the home where he was staying in Senegal.

Associated Press writer Babacar Dione in Dakar, Senegal contributed to this report.

You've read  of  free articles. Subscribe to continue.
Real news can be honest, hopeful, credible, constructive.
What is the Monitor difference? Tackling the tough headlines – with humanity. Listening to sources – with respect. Seeing the story that others are missing by reporting what so often gets overlooked: the values that connect us. That’s Monitor reporting – news that changes how you see the world.

Dear Reader,

About a year ago, I happened upon this statement about the Monitor in the Harvard Business Review – under the charming heading of “do things that don’t interest you”:

“Many things that end up” being meaningful, writes social scientist Joseph Grenny, “have come from conference workshops, articles, or online videos that began as a chore and ended with an insight. My work in Kenya, for example, was heavily influenced by a Christian Science Monitor article I had forced myself to read 10 years earlier. Sometimes, we call things ‘boring’ simply because they lie outside the box we are currently in.”

If you were to come up with a punchline to a joke about the Monitor, that would probably be it. We’re seen as being global, fair, insightful, and perhaps a bit too earnest. We’re the bran muffin of journalism.

But you know what? We change lives. And I’m going to argue that we change lives precisely because we force open that too-small box that most human beings think they live in.

The Monitor is a peculiar little publication that’s hard for the world to figure out. We’re run by a church, but we’re not only for church members and we’re not about converting people. We’re known as being fair even as the world becomes as polarized as at any time since the newspaper’s founding in 1908.

We have a mission beyond circulation, we want to bridge divides. We’re about kicking down the door of thought everywhere and saying, “You are bigger and more capable than you realize. And we can prove it.”

If you’re looking for bran muffin journalism, you can subscribe to the Monitor for $15. You’ll get the Monitor Weekly magazine, the Monitor Daily email, and unlimited access to CSMonitor.com.

QR Code to Ebola survivor urges increased production of experimental drug
Read this article in
https://www.csmonitor.com/World/Latest-News-Wires/2014/0830/Ebola-survivor-urges-increased-production-of-experimental-drug
QR Code to Subscription page
Start your subscription today
https://www.csmonitor.com/subscribe